Molecular imaging in breast cancer
David M Schuster1, Raghuveer K Halkar
1Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Emory University Hospital, 1364 Clifton Road, NE, Atlanta, GA 30322, USA. David_Schuster@emoryhealthcare.org
Abstract:
Since the 1960s, bone scanning has played a major role in the management of breast cancer. In the last decade, however, the role of radionuclide molecular imaging has expanded significantly in the clinical management of breast cancer because of fluorodeoxyglucose positron emission tomography, mammoscintigraphy, and sentinel lymph node techniques. Molecular imaging also is instrumental in drug development,gene therapy, and in basic science research of breast cancer. This article provides a comprehensive review of the role of molecular imaging of breast cancer in clinical practice and reports on the current state of research in this field.
Insights
Molecular imaging, including PET scans, has advanced breast cancer management since the 1960s. These techniques are crucial for clinical practice, drug development, and research in breast cancer.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiology
Background:
- Bone scanning has been a cornerstone in breast cancer management since the 1960s.
- Recent advancements have significantly expanded the role of radionuclide molecular imaging.
- Key techniques include fluorodeoxyglucose positron emission tomography (FDG-PET), mammoscintigraphy, and sentinel lymph node imaging.
Purpose of the Study:
- To provide a comprehensive review of molecular imaging in breast cancer clinical practice.
- To report on the current research landscape of molecular imaging for breast cancer.
- To highlight the expanding applications of molecular imaging in oncology.
Main Methods:
- Review of existing literature on molecular imaging techniques in breast cancer.
- Analysis of the clinical utility of techniques like FDG-PET, mammoscintigraphy, and sentinel lymph node biopsy.
- Examination of molecular imaging's role in drug development, gene therapy, and basic research.
Main Results:
- Molecular imaging has become integral to breast cancer management, offering detailed insights beyond traditional methods.
- Techniques like FDG-PET and sentinel lymph node imaging have demonstrated significant clinical value.
- Molecular imaging is instrumental in advancing breast cancer research and therapeutic strategies.
Conclusions:
- Molecular imaging plays a vital and expanding role in the clinical management of breast cancer.
- Its applications extend to crucial areas of drug development, gene therapy, and fundamental research.
- Continued research is essential to further optimize and broaden the use of molecular imaging in breast cancer care.
